All In Biotech

Drug Trial Radar · NCT01254552

Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis

Assessment With Cardiac Computed Tomography Angiography (CCTA) and Magnetic Resonance Imaging (MRI) in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis

Last checked: Nov 20, 2026Latest source record: May 31, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

351

Actual

Start

Aug 2010

Primary completion

Sep 2011

Study completion Oct 2016

Sponsor

Lead sponsor
GuerbetIndustry
Sponsor type
Industry
First posted
Dec 6, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 50 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study aimed to prospectively investigate the prevalence of myocardial scar on Dotarem-enhanced Cardiovascular Magnetic Resonance Imaging (MRI) in asymptomatic patients with type-2 Diabetes Mellitus and to assess its correlation with subclinical coronary artery disease on Cardiac Computed Tomography Angiography (CCTA).

Conditions

  • Type 2 Diabetes Mellitus
  • Coronary Atherosclerosis

Interventions

  • iobitridolDrug

    Xenetix 350 was administered at a dose up to 180 ml, according to the patient's body weight measured on the day of administration.

  • gadoterate meglumineDrug

    Dotarem was administered at a dose of 0.1 mmol/kg body weight (0.2 ml/kg body weight)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Prevalence of Occult Myocardial Scar on Delayed-enhanced MRI in Asymptomatic Patients With Type 2 Diabetes MellitusTime frame: From 1 week to 2 months (after the collection of data corresponding to cardiac MRI and CCTA examinations)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Asan Medical Center

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.